Kaisa Health Group Holdings Limited announced the shareholders of the Company (the "Shareholders") and potential investors that, based on a preliminary assessment on the unaudited consolidated accounts of the Group for the year ended 31 December 2022 and the information currently available to the Board, the Group is expected to record a loss attributable to the owners of the Company in the range of HKD 110 million to HKD 130 million for the year ended 31 December 2022 as compared to the profit attributable to the owners of the Company in the amount of approximately HKD 2 million for the year ended 31 December 2021.
Kaisa Health Group Holdings Limited
Equities
876
BMG522111027
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 HKD | -3.85% | +4.17% | -26.47% |
25/03 | Kaisa Health Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
19/03 | Kaisa Health Group Holdings Expects HK$7 Million Profit in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
-26.47% | 16.81M | |
+2.73% | 19.09B | |
+6.62% | 13.98B | |
+13.58% | 10.62B | |
-10.48% | 2.24B | |
+4.19% | 1.78B | |
+25.11% | 1.64B | |
+17.44% | 639M | |
0.00% | 372M | |
+90.38% | 223M |
- Stock Market
- Equities
- 876 Stock
- News Kaisa Health Group Holdings Limited
- Kaisa Health Group Holdings Provides Earnings Guidance for the Year Ended December 31, 2022